President Joe Biden announced that his administration is on track to have enough anti-coronavirus vaccine supply for every adult in the United States by the end of May.
To achieve this target, Johnson & Johnson will work with Merck to expand the production of the single-shot coronavirus vaccine developed by its vaccine division, Janssen Biotech.
For comments and feedback contact: editorial@rttnews.com
Health News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.